FDA Approved Therapy for SOD1 Associated...

Dr. Andy Southerland talks with Dr. Matthew Gusler about trends in emergent interfacility transfers for ischemic stroke and factors associated with transfer for care. Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Dr. Zohaib Siddiqi talks with Dr. Michel Toledano about the diagnosis and management of infectious rhombencephalitis in patients receiving immunomodulatory therapy. Read the related Resident & Fellow Section article in Neurology®. Disclosures can be found at Neurology.org. 

Dr. Matthew Barrett talks with Dr. Elan Louis about the incidence and prevalence of mild cognitive impairment and dementia in essential tremor and what these findings may mean for patient care and future research. Read the related article in Neurology®. Disclosures can be found a ... Show More

Dr. Gordon Smith talks with Laynie Dratch about integrating genetic testing into patient care for persons with Amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) spectrum disorders. 

In the first episode of a two-part series, Dr. Joseph Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medication ... Show More

<p class="MsoNormal">In today's episode, host Dr. Amanda Redfern invites Dr. Nancy Newman to share updates in the treatment of Leber hereditary optic neuropathy (LHON), covering several clinical trials underway that involve idebenone and gene therapy. </p> <p class="MsoNormal">Fo ... Show More

ALS is a disease that destroys the nerve cells in the brain and spinal cord we need for voluntary movement. There is no cure, but now there is a newly approved medication that may slow down the disease and extend patients' lives. The drug, called Relyvrio, got its start with a co ... Show More

As medical professionals search for new treatments to help Covid-19 patients, some researchers are taking a second look at drugs that have already been approved by the FDA. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to Dr. David Fajgenbaum about repurposing old drugs ... Show More

Jimi Olaghere feels like he’s been reborn after a pioneering new treatment for sickle cell disease. Scientists have engineered his blood to overcome the disease that left him in constant pain. I speak to Jimi about his experience and to his doctors about what this could mean for ... Show More

Send us Fan MailIn this episode, we discuss the approach to a patient with SVC syndrome. This includes considering both malignant and non-malignant causes. Treatment focuses on relief of the obstruction and investigation and management of malignant causes. Our medicine minute dis ... Show More

In the final episode of this two-part series, Dr. Joe Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medication ... Show More